A new study suggests that the cholesterol-regulating protein PCSK9 may serve as a sensitive early biomarker for autoimmune ...

Research suggests certain blood types may be linked to a higher risk of developing serious or fatal liver disease. Scientists ...

Learn how blood types A, B, and O may influence susceptibility and risk assessment for autoimmune liver disease.

Please contact your Oppenheimer representative to register for the Movers in Rare Disease Summit and to schedule a 1x1 meeting with Dr. Mor and Chemomab management.

THERE are few things as satisfying as scratching an itch. But when your itch keeps recurring and starts to affect your day-to ...

Esperion Therapeutics has recently seen a slight increase in its fair value target, moving from $6.10 to $6.15 per share following adjustments to analysts’ expectations. This modest revision reflects ...

Alex Cornish, a mum-of-two from near Brecon, said a "dark cloud has lifted" after she received a new liver using a pioneering.

Chemomab Therapeutics Ltd. ( ($CMMB) ) has released its Q3 earnings. Here is a breakdown of the information Chemomab Therapeutics Ltd. presented ...

In this video, Nancy S. Reau, MD, FAASLD, AGAF, discusses the impact of linerixibat on potential mediators of pruritus in patients with primary biliary cholangitis from the phase 3 double-blind, ...

A Sennybridge mother who received a life-saving liver transplant earlier this year says a “revolutionary” technique being ...